Why Amazon should keep prescription drugs off its voluminous shelves

June 7, 2017 by C. Michael White, The Conversation
Credit: Susan Buck Ms/Public Domain

Amazon hit a milestone this month after the price of one share hit US$1,000 for the first time, giving it a total value of close to $500 billion. That makes it the fourth-biggest company in the U.S. in terms of market capitalization and twice the size of brick-and-mortar rival Walmart.

The 's incredible growth has come from expanding into more and more areas of the economy, providing its customers with speedy delivery of everything from socks and books to lawn chairs and computers. One category it has yet to enter, however, is .

Amazon wants to change that and dispense drugs alongside its hundreds of millions of other wares. Would this be a good thing for consumers and the health care system?

The biggest online retailer's entry into this market may lead to efficiency gains, but the cost would be dear in terms of further severing the link between patients and actual pharmacists. Research, including my own, shows that patients need more face-to-face time with pharmacists, not less.

Brief history of pharmacies

Pharmacies (or apothecaries, as they were once known) have existed since antiquity. The first retail pharmacy began in Philadelphia in 1729. Back then, pharmacists not only dispensed medications to patients (without a prescription) but diagnosed diseases and handcrafted drugs. In 1951, Congress passed the Federal Food, Drug and Cosmetic Act, which prohibited pharmacists from dispensing FDA-approved drugs without a valid prescription.

Mail-order pharmacies harnessing the raw efficiency of mass-filling began to boom in the 1980s. In 2013, about 39 percent of customers said they refilled their prescription by mail order, up from an estimated 6 percent in 1990.

Clearly it costs less per unit of labor for prescriptions to be filled in a centralized facility with industrial pill counting technology and with auto-refills of medication than when prescriptions are filled manually in the store by a local pharmacist triggered by a patient calling the pharmacy.

Consumers say they like the convenience of mail-order pharmacies, which is likely one of the reasons Amazon is getting serious about entering the $450 billion market for prescription drugs.

Amazon might be able to enhance the user experience, as well as make the process even more efficient, but there's a cost.

Drugs aren't socks

What is missing from the discussion is that prescription drugs are not socks or refrigerators. When consumers take drugs, they become patients, not just customers.

While prescription drugs hold the promise of preventing disease and treating symptoms, they can maim or even kill if not used correctly.

In 1993, for example, medication-related errors led to about 7,400 deaths, more than double the number of fatalities in 1983, according to a review of death certifications. Unfortunately, they're the latest data available, but most likely the number is higher today.

A key reason for these errors seems to be a lack of communication. A 2003 report noted that better communication among physicians, pharmacists and nurses could prevent 86 percent of the most serious medication errors, which suggests shifting more dispensation to a centralized facility from local pharmacies would worsen the problem.

Too many people aren't taking their meds

Another thing that makes prescription drugs very different than Amazon's typical offerings is that in many cases it's essential that patients actually take their meds as prescribed. That's not happening.

Taking drugs in the right dosage for the right amount of time is critical to effectively cure a disease, prevent the formation of antimicrobial resistance and keep a malady from progressing.

Yet on average, only about 50 percent of American patients typically take their medicines as prescribed, costing hundreds of billions of dollars in adverse outcomes and unnecessary hospitalizations each year.

Furthermore, in my own research involving patients with cardiovascular diseases, I have found that people are simply not receiving the medications they need – and when they are, they aren't following through on the required dosage, leading to worse outcomes. I've found that greater interaction between patients and pharmacists can help solve this problem.

Other studies have shown that more active face-to-face engagement with a pharmacist improves a patient's level of adherence to a prescription, which can lead to better outcomes. A study involving Walgreens pharmacists, for example, suggested direct drug counseling reduced costs by $266 on average, mostly due to fewer hospitalizations.

The environmental costs

Finally, another key aspect of prescription drugs is that their waste is a big and growing problem.

Unlike the clothes or appliances you order, medications can't simply be returned to the merchant, restocked and resold to another customer. There's no way of ensuring they weren't adulterated or improperly stored, and the risks are too great. That means every pill that goes unused must be disposed of, which is a huge waste of money but also is a major source of pollution.

In a 2015 assessment of medications turned in for disposal, more than half of the prescriptions purchased from mail-order pharmacies still contained 80 percent of more of the original pills. Even more troubling, 39 percent had every single pill originally dispensed. That compares with much-lower rates of 37 percent and 17 percent for community pharmacies.

Many of the unused drugs, however, aren't properly disposed of and instead end up in a landfill or flushed down a toilet.

A nationwide study conducted by the U.S. Geological Survey in 1999 and 2000 found low levels of pharmaceuticals – including antibiotics, hormones, contraceptives and steroids – in 80 percent of the rivers and streams sampled, contaminating 40 million Americans' drinking water.

Studies have shown that aquatic animals are adversely affected by these hormones, with some male fish developing female sex organs, and there are concerns that long-term exposure to a tainted water supply can lead to more superbugs.

Small gains for many pains

Amazon is a revolutionary company that has reshaped how we shop and has helped drastically increase the efficiency of shipping small packages. This could even allow it to reduce some of the negative side effects, noted above, of remote pharmacies, such as by making it more cost-effective to ship small quantities of pills to reduce waste.

But to my mind, any modest gains in efficiencies or cost savings are paid for dearly by the negative outcomes that result from medication-related errors and not following through on their prescriptions, while the waste of unused drugs will continue. And while this problem has been with us for a while, Amazon, due to its size and ability to quickly dominate markets, would make the situation a lot worse.

Delivering a product more efficiently cannot be the only metric of success. With prescription drugs, saving lives must be considered as well.

Explore further: Counterfeit drugs, spoiled pills and unsupervised treatments are a few of the risks of using online pharmacies

Related Stories

Counterfeit drugs, spoiled pills and unsupervised treatments are a few of the risks of using online pharmacies

July 29, 2016
With the rise of on-demand delivery, prescription medicine joins the countless list of items that can be ordered online with the click of a button.

Stroke survivors using mail order pharmacies more likely to take meds

February 19, 2016
Stroke survivors who get medications by mail are more likely to take them as directed than patients who get medications from local pharmacies, according to research presented at the American Stroke Association's International ...

Pharmacists report hidden fees that distort prescription costs

July 8, 2016
(HealthDay)—Pharmacists often encounter fees imposed by prescription drug "middlemen" that adversely impact both pharmacies and patients and distort medication costs and reimbursement rates, according to a report from the ...

End pharmacists' monopoly on selling certain drugs, argues expert

July 1, 2015
Evidence is lacking that having a category of drugs that can be sold only by pharmacists or under their supervision ("pharmacy medicines") has benefits, writes a pharmacy professor in The BMJ this week.

CVS to pay Massachusetts $795K, tighten policies for opioids

September 1, 2016
CVS Health Corp. has agreed to pay Massachusetts $795,000 and will tighten its policies for dispensing opioids following an investigation into its drug prescription practices, Attorney General Maura Healey said Thursday.

Many Americans earn low grades for proper med use: survey

June 25, 2013
(HealthDay)—Americans get an average of C+ on the proper use of medications, and one in seven even gets an F, a new report card shows.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.